1. Home
  2. CVAC vs BYON Comparison

CVAC vs BYON Comparison

Compare CVAC & BYON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • BYON
  • Stock Information
  • Founded
  • CVAC 2000
  • BYON 1997
  • Country
  • CVAC Germany
  • BYON United States
  • Employees
  • CVAC N/A
  • BYON N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • BYON Catalog/Specialty Distribution
  • Sector
  • CVAC Health Care
  • BYON Consumer Discretionary
  • Exchange
  • CVAC Nasdaq
  • BYON Nasdaq
  • Market Cap
  • CVAC 643.8M
  • BYON 450.6M
  • IPO Year
  • CVAC 2020
  • BYON N/A
  • Fundamental
  • Price
  • CVAC $2.82
  • BYON $10.11
  • Analyst Decision
  • CVAC Hold
  • BYON Buy
  • Analyst Count
  • CVAC 3
  • BYON 8
  • Target Price
  • CVAC $10.00
  • BYON $22.86
  • AVG Volume (30 Days)
  • CVAC 399.6K
  • BYON 1.6M
  • Earning Date
  • CVAC 11-12-2024
  • BYON 10-24-2024
  • Dividend Yield
  • CVAC N/A
  • BYON N/A
  • EPS Growth
  • CVAC N/A
  • BYON N/A
  • EPS
  • CVAC N/A
  • BYON N/A
  • Revenue
  • CVAC $70,565,734.00
  • BYON $1,538,156,000.00
  • Revenue This Year
  • CVAC $105.61
  • BYON N/A
  • Revenue Next Year
  • CVAC N/A
  • BYON $11.10
  • P/E Ratio
  • CVAC N/A
  • BYON N/A
  • Revenue Growth
  • CVAC 75.11
  • BYON N/A
  • 52 Week Low
  • CVAC $2.22
  • BYON $8.91
  • 52 Week High
  • CVAC $6.30
  • BYON $37.10
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 38.84
  • BYON 48.37
  • Support Level
  • CVAC $2.79
  • BYON $9.89
  • Resistance Level
  • CVAC $2.89
  • BYON $10.72
  • Average True Range (ATR)
  • CVAC 0.11
  • BYON 0.60
  • MACD
  • CVAC -0.01
  • BYON 0.05
  • Stochastic Oscillator
  • CVAC 19.44
  • BYON 60.92

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad range of products, including furniture, décor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

Share on Social Networks: